- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2026 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Latest Conference Articles
.png?w=350&fit=crop&auto=format)
CPHI Milan Puts Sustainability to Work, Part 2
August 14th 2026
In part 2 of this 2-part interview, Silvia Forroova, director of Partnerships & Sustainability at CPHI, and founder of the CPHI Sustainability Collective, tells PharmTech about the challenges in achieving sustainability in pharma and how the CPHI Sustainability Summit, which launches at CPHI Milan 2026, can help organizations tackle these challenges.
CPHI Milan Puts Sustainability to Work, Part 1
August 13th 2026
PharmTech spoke with Silvia Forroova, director of Partnerships & Sustainability at CPHI, and founder of the CPHI Sustainability Collective, about the new Sustainability Summit that will launch at CPHI Milan 2026 and how it can help organizations obtain measurable, commercially viable solutions for sustainability in the pharma industry.
.png?w=350&fit=crop&auto=format)
CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda
August 11th 2026
This year’s conference agenda includes more than 260 industry experts, a new Sustainability Summit, and zones targeting AI, cold chain, and labeling.
Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth
June 12th 2026
Tom Sellig, Adare, discusses 3D-printed tablets, US reshoring investment, FDA timeline pressures, and workforce development strategies driving CDMO growth.
Q&A: Molly Klote on Dual Sourcing, Regionalization, and the New Pharma Normal
June 11th 2026
Molly Klote, Klote Medical Research Advisors, discusses how pharma must move beyond tariff-driven reactions to build evidence-based, quality-led supply chain resilience that satisfies FDA scrutiny and protects patient access.
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
June 8th 2026
Pharmaceutical suppliers face growing pressure to calculate product carbon footprints as customer requirements and global regulations tighten.
Tom Sellig on CDMO Innovation and US Manufacturing Growth
June 5th 2026
Tom Sellig, Adare Pharma Solutions, shares how the CDMO is positioning for growth amid US reshoring and oral dose innovation trends.
Molly Klote on Reshoring, Tariffs, and the Future of Pharma Supply Chains
June 4th 2026
At CPHI Americas, Molly Klote, Klote Medical Research Advisors, spoke about how the pharma industry faces tariff volatility and reshoring pressure. She warned FDA wants actionable supply chain plans, not slogans, with quality built in.
Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security
June 4th 2026
At CPHI Americas, Delaware Gov. Matt Meyer argues domestic pharma manufacturing is a national security priority and positions Delaware as the ideal reshoring hub.
CPHI Americas: How FDA Instability Is Reshaping Pharmaceutical Development
June 2nd 2026
FDA instability, staff turnover, and evolving review standards are reshaping drug development. Richard Pazdur, formerly with the FDA, shares what sponsors need to know now.